feed,title,long_url,short_url
Benzinga,Fulcrum Therapeutics Presents Updated Data on Sickle Cell Disease Program at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition,https://www.benzinga.com/pressreleases/20/12/g18662933/fulcrum-therapeutics-presents-updated-data-on-sickle-cell-disease-program-at-the-62nd-american-soc,https://j.mp/3qrAEN7
Benzinga,Intellia Therapeutics Presents New Preclinical Data Supporting Its CRISPR/Cas9-Engineered TCR-T Cell Treatment for Acute Myeloid Leukemia at the 62nd ASH Annual Meeting,https://www.benzinga.com/pressreleases/20/12/g18662932/intellia-therapeutics-presents-new-preclinical-data-supporting-its-crisprcas9-engineered-tcr-t-cel,https://j.mp/3lLJYI2
